Resuscitation Rambo: Niels Högel and the Largest Serial Murder Trial in German Post-War History
In the cardiac intensive care units where Niels Högel worked, he was known for a particular kind of excellence. When a patient went into cardiac arrest, Högel was there. He was fast. He was calm. He knew the resuscitation protocols. Colleagues praised his ability in a crisis. Some of them gave him a nickname: “Resuscitation Rambo.” The praise was real. The crises were not. Högel was creating the emergencies he was then praised for responding to, by injecting patients with lethal doses of cardiac drugs and then attempting to revive them for an audience of colleagues who had no idea what they were watching.
On June 6, 2019, a district court in Oldenburg, Germany, convicted Niels Högel of 85 separate counts of murder. He was found guilty of killing 85 patients at two hospitals between 2000 and 2005. Estimates of the total number of people he killed, drawn from investigation of 200 suspicious deaths across his employment history and from his own incomplete and inconsistent confessions, reach as high as 300. He is, by any measure, one of the most prolific serial killers in the history of peacetime Germany, and possibly the world.
Background: The Nurse Who Wanted to Be the Hero
Niels Högel was born on December 30, 1976, in Wilhelmshaven, a coastal city in Lower Saxony. His background in nursing was familial: his father was a nurse at the local hospital, and his grandmother had also worked as a nurse. He completed his vocational training in nursing in 1997 at the Sankt-Willehad-Hospital in Wilhelmshaven and then moved to the cardiac intensive care unit at the Klinikum Oldenburg, one of the larger hospitals in the region, where he worked from 1999.
The killings at Oldenburg began in approximately 2000. By 2002, the hospital had grown sufficiently concerned about the pattern of events on Högel’s shifts that he was dismissed. He obtained a position at the Klinikum Delmenhorst, a smaller hospital in a town near Bremen, without any disclosure from Oldenburg about the concerns that had accompanied his departure. The killings continued at Delmenhorst. He was caught there in June 2005 when a colleague observed him injecting a drug into a patient’s IV line; the patient immediately went into cardiac arrest. The colleague identified the drug as ajmaline, a cardiac antiarrhythmic that in excessive doses can cause the very cardiac arrest it is used to treat. Högel was arrested.
The Drugs and the Method
Högel’s method was to inject patients with unprescribed cardiac medications: ajmaline, sotalol, amiodarone, lidocaine, potassium, and calcium chloride. Each of these drugs has legitimate uses in the management of cardiac arrhythmias, and each, in excessive doses, can cause the cardiac arrest and haemodynamic collapse that constitutes a life-threatening emergency. By introducing these drugs into patients’ IV lines without prescription or clinical justification, Högel created medical crises that were indistinguishable, at the time of occurrence, from spontaneous deterioration in already seriously ill cardiac patients.
He then participated in the resuscitation attempts. In many cases, the attempts succeeded; investigators established that approximately sixty of the patients Högel attacked at Delmenhorst alone were successfully resuscitated. It was only in the cases where resuscitation failed that the attack resulted in death. Högel himself acknowledged, when questioned about his motive, that he wanted to impress colleagues with his resuscitation skills. The praise he received for his performance in crises of his own making was, by his account, the primary reward he sought. Prosecutors in the 2019 trial characterised this motive as “base” under German criminal law, meaning it reflected a desire to impress or show off rather than any mercy-killing rationale, and found the designation appropriate for the murder charge.
The Scale of the Investigation
When Högel was first arrested in 2005, the scope of what he had done was not yet understood. He was charged with attempted murder in relation to the Delmenhorst incident where he had been directly observed. A 2008 trial convicted him of attempted murder at Delmenhorst and two murders at Oldenburg, resulting in a seven-year sentence that was later increased to life imprisonment. It was only when that trial produced a formal criminal record that investigators began looking more systematically at the full history of his employment.
In October 2014, a dedicated police commission called “Kardio” was established to investigate suspicious deaths across all of Högel’s workplaces. By August 2017, investigators announced they had concluded he was responsible for at least 90 patient deaths. By November 2017, that number had increased to 106. In January 2018, prosecutors charged him with the murder of 97 patients. The 2018-2019 trial, which was one of the largest criminal proceedings in German post-war history, ran over 24 days of hearings.
At the trial, Högel confessed to 43 killings on the first day. He said he could not recall the remaining deaths he was charged with, and denied involvement in five. On June 6, 2019, Judge Sebastian Bührmann convicted him on 85 of the 100 murder charges and acquitted him on 15, noting that the court had been unable to obtain sufficient evidence on those specific deaths to satisfy the standard of proof beyond reasonable doubt. Sentencing included a finding of “particular severity of guilt,” a German legal mechanism that significantly complicates any prospect of parole after the standard minimum term.
Judge Bührmann addressed the scale of what he had heard with a phrase that stayed with observers: “I feel like an accountant of death.” He told Högel: “Your guilt is unimaginable. The human mind struggles to take in the sheer scale of these crimes.”
The Institutional Failures
The pattern of institutional failure in the Högel case is, by now, a familiar one. Oldenburg recognised that something was wrong with the pattern of crises on Högel’s shifts but dismissed him without reporting to any regulatory authority or to the German equivalent of a practitioner data bank. The reference provided by Oldenburg when Delmenhorst hired Högel was, in the investigators’ characterisation, “clean.” Colleagues at Delmenhorst later acknowledged that they had noticed “irregularities” in Högel’s behaviour but had not escalated them. The patient who died in the incident that led to his arrest in 2005 was not the first suspicious death at Delmenhorst; it was simply the one where he was directly observed in the act.
In February 2022, a separate trial opened against seven former supervisors at the two hospitals, charged with negligent homicide for their failure to act on warning signs about Högel’s conduct. This represented an unusual step in German criminal law: the prosecution of supervisory personnel for the deaths that resulted from their failure to prevent a subordinate’s killing. The prosecution’s theory was that the supervisors had received sufficient information to have intervened and that their failure to do so was criminally negligent. The outcome of those proceedings is part of the ongoing legal reckoning with how an institution allows a nurse to kill dozens of patients over years without formal response.
What the Case Establishes About Healthcare Serial Killing
The Högel case demonstrates, at a scale and with a degree of documentation unusual even among healthcare serial killer cases, the specific conditions that allow this kind of harm to continue. The drugs were legitimately present on the ward; their diversion required only the willingness to act, not any special access to restricted materials. The victims were already ill enough that their deterioration was plausible without external cause. The perpetrator was skilled enough at genuine resuscitation that his performance in the crises he engineered was impressive and praise-worthy. And the institutional response to early warning signs chose internal management over external reporting, passing a killer from one hospital to another in a manner identical to the pattern seen in virtually every healthcare serial killer case across multiple countries.
The Högel case also produced, in the 2022 supervisory prosecution, something that few healthcare serial killer cases have: a legal theory of institutional accountability for failure to act. Whether supervisors who fail to report credible warning signs about a dangerous healthcare worker should face criminal liability for the deaths that follow is a question with significant implications for how institutions respond to these situations. The German criminal law’s answer, pursued through the 2022 prosecution, is that in some circumstances, yes.
TL;DR: Key Facts, Legal Concepts, and Why This Case Matters
Who was Niels Högel?
Niels Högel (born December 30, 1976, in Wilhelmshaven, Lower Saxony) was a German intensive care nurse who worked at the Klinikum Oldenburg and Klinikum Delmenhorst between approximately 1999 and 2005. He was convicted in June 2019 of 85 counts of murder and is currently serving a life sentence. He is estimated to have killed between 85 and 300 patients, making him the most prolific known serial killer in post-war German history and possibly the world.
What drugs did he use and how?
Högel injected patients with unprescribed cardiac medications including ajmaline, sotalol, amiodarone, lidocaine, potassium, and calcium chloride, all drugs legitimately used in cardiac care that in excessive or injudicious doses can cause cardiac arrest. By introducing these drugs into patients’ IV lines without prescription or clinical indication, he created the emergencies he then participated in responding to. In approximately 60 of his attacks at Delmenhorst alone, resuscitation succeeded. In the remainder, the patients died.
Why did he do it?
Högel told investigators and the court that he was motivated by the desire to demonstrate his resuscitation skills and to receive praise from colleagues for his performance in emergencies. He wanted to be seen as the competent, capable nurse who saved patients in crisis. The court found this motive to be “base” within the meaning of German murder law, meaning it reflected a desire to show off rather than any therapeutic intention. He also admitted that in some cases he could no longer remember specific victims, suggesting that the killings had become normalised for him over time.
How was he caught?
Högel was initially caught in June 2005 at Klinikum Delmenhorst when a colleague directly observed him injecting ajmaline into a patient’s IV line. The patient immediately went into cardiac arrest. This single observation, combined with the subsequent investigation into deaths at Delmenhorst, produced an initial conviction in 2008. It was the later systematic investigation by the “Kardio” commission, established in 2014, that identified the full scope of his killings across both hospitals.
Were institutional supervisors held accountable?
In February 2022, a separate trial opened in Germany against seven former supervisors from the Klinikum Oldenburg and Klinikum Delmenhorst who were charged with negligent homicide for failing to act on warning signs about Högel’s conduct. Klinikum Oldenburg had dismissed Högel in 2002 due to concerns about the pattern of events on his shifts but had given him a clean reference for his subsequent employment at Delmenhorst. The prosecution of supervisory personnel for deaths resulting from failure to prevent a subordinate’s conduct represents a significant application of criminal liability to institutional inaction in healthcare settings.
What is the significance of the 2019 trial?
The 2019 trial of Niels Högel was one of the largest criminal proceedings in post-war German history, with 100 murder charges, 24 days of hearings, and 32 witnesses. It produced 85 murder convictions and a finding of “particular severity of guilt” that complicates early parole. It has been studied extensively as an example of healthcare serial killing at an almost unprecedented scale, and as a case study in how institutions that discover warning signs about a dangerous employee can make the decision to manage the situation internally rather than report it, with catastrophic consequences for the patients who encounter the same employee at the next institution.
